{"nct_id":"NCT02383927","title":"Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2015-05-13","start_date_type":null,"primary_completion_date":"2020-12-14","primary_completion_date_type":"ACTUAL","completion_date":"2020-12-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["KURA"]}